BioLargo Adds Cleantech Investment Pioneer Walter L. Schindler as a Strategic Advisor
Santa Ana, CA, May 26, 2015 (Newswire.com) - BioLargo, Inc. (OTCQB: BLGO) announced today that Walter L. Schindler had joined the company as a strategic advisor. He is working closely with management to assist the company in developing important strategic customer alliances and pursing global licensing opportunities for its AOS Filter as the lowest cost solution for eliminating all contaminants from water, including converting fracking produced wastewater into useable water for agriculture.
About Walter L. Schindler
Walter is the founder and a Managing Partner of SAIL Capital Partners LLC. Under his leadership SAIL was been selected by the World Economic Forum as a member of its Community of Global Growth Companies and nominated for Private Equity Manager of the Year by Foundation & Endowment Money Management. In addition, SAIL Capital was chosen by the U.S. Department of Commerce to co-lead with Deutsche Bank the U.S. Trade Mission on Clean Energy to Germany and to participate in the first Impact & Sustainable Trade Mission to Europe with investor meetings in Zurich, Amsterdam, and London. He serves on the Board of Directors of Fulbright Canada, the Foundation for Educational Exchange between Canada and the United States of America (www.fulbright.ca). Walter is also a member of the Board of Directors of CNS Response Inc., as well as a member of the North American Advisory Board of The Cleantech Group, the Advisory Board of US Bank, and the Chief Executive Roundtable of the University of California at Irvine.
Prior to his work with Sail, Walter served as the partner in charge of Gibson, Dunn & Crutcher’s Orange County, California office, one of the largest in its worldwide network. His 19-year career at this leading international law firm included advising clients on some of the most successful IPO’s and mergers in the US during that time, including Allergan, Callaway Golf, Fluor, Pacific Mutual Life Insurance Company (PIMCO), PacifiCare, SafeGuard Health, and Ultrasystems. He was the lead strategic advisor in over 60 successful mergers, acquisitions, and IPO’s. His assignments included advising Pacific Mutual Life Insurance with regard to the creation and execution of the exit strategy for its investment in PIMCO and working on the IPO of Ultrasystems Inc., the first renewable power project developer to go public in the US. He has 30 years of broad and deep experience in energy and renewable power projects and related exit experience.
Walter is a native of New Orleans, earned his B.A., M.A. and Ph.D. with honors from Yale University and his J.D. with honors from Harvard Law School, and studied as a Fulbright Scholar in Italy. At Yale was awarded the Mary Cady Tew Prize. He is the author of a book of original poetry (The Napoleon House) and a book on the life and poetry of John Milton (Voice and Crisis: Invocation in Milton’s Poetry).
Dennis Calvert, President and CEO of BioLargo commented, “We are thankful to have Walter on our team as we advance towards commercialization of our AOS Filter.”
Walter added, “My work over the past ten years has focused on financing, developing and commercializing global, sustainable and disruptive technologies. I believe that BioLargo has a significant role to play in several large global industries like oil & gas, fracking, agriculture and food. For this reason I am a strategic advisor and shareholder.”
About BioLargo, Inc.
BioLargo, Inc. (OTCQB: BLGO) makes life better by delivering technology-based products that help solve some of the world's most important problems that threaten water, food, agriculture, healthcare and energy. More information can be found about the company and its subsidiaries at www.BioLargo.com. The subsidiary BioLargo Water, Inc. (www.BioLargoWater.com) showcases the Advanced Oxidation Systems, including its AOS Filter, a product in development specifically designed to eliminate common, troublesome, and dangerous (toxic) contaminants in water in a fraction of the time and cost of current technologies. BioLargo also owns a 50% interest in the Isan System, which was honored with a "Top 50 Water Company for the 21st Century" award by the Artemis Project. The subsidiary Odor-No-More Inc., features award-winning products serving the pet, equine, and consumer markets, including the Nature's Best Solution® and Deodorall® brands. (www.OdorNoMore.com). The subsidiary Clyra Medical Technologies, Inc. (www.ClyraMedical.com), focuses on advanced wound care management and is preparing to make FDA 510(k) applications.
Safe Harbor Statement
The statements contained herein, which are not historical, are forward-looking statements that are subject to risks and uncertainties that could cause actual results to differ materially from those expressed in the forward-looking statements, including, but not limited to, the risks and uncertainties included in BioLargo's current and future filings with the Securities and Exchange Commission, including those set forth in BioLargo's Annual Report on Form 10-K for the year ended December 31, 2014.